Not applicableStudy completedNCT03055065What this trial is testingADenoVirus Initiative Study in Epidemiology in ItalyWho this might be right forViral Conjunctivitis NicOx 241
Large-scale testing (Phase 3)Study completedNCT00244543What this trial is testingEvaluation of Efficacy of Ophthalmic Solution in Induced Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Vistakon Pharmaceuticals 110
Post-approval studies (Phase 4)Study completedNCT01732757What this trial is testingEvaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic ConjunctivitisWho this might be right forConjunctivitis, Allergic Allergan 157
Large-scale testing (Phase 3)Study completedNCT01799863What this trial is testingArtificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral ConjunctivitisWho this might be right forConjunctivitis, Viral Fundação Altino Ventura 50
Not applicableStudy completedNCT02054273What this trial is testingADenoVirus Initiative Study in Epidemiology in GermanyWho this might be right forViral Conjunctivitis NicOx 240
Testing effectiveness (Phase 2)Ended earlyNCT00941486What this trial is testingFST-100 Ophthalmic Suspension in Acute Adenoviral ConjunctivitisWho this might be right forAcute Adenoviral Conjunctivitis Shire 30
Large-scale testing (Phase 3)Study completedNCT00348348What this trial is testingInvestigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial ConjunctivitisWho this might be right forAcute Bacterial Conjunctivitis Bausch & Lomb Incorporated 1,161
Large-scale testing (Phase 3)Study completedNCT00347932What this trial is testingDetermine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.Who this might be right forAcute Bacterial Conjunctivitis Bausch & Lomb Incorporated 957
Large-scale testing (Phase 3)Study completedNCT00424398What this trial is testingEvaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic ConjunctivitisWho this might be right forConjunctivitis, Allergic Bausch & Lomb Incorporated 107
Large-scale testing (Phase 3)Study completedNCT01881113What this trial is testingA Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to VehicleWho this might be right forAllergic Conjunctivitis Aciex Therapeutics, Inc. 101
Post-approval studies (Phase 4)Study completedNCT01470118What this trial is testingEvaluate the Duration of LASTACAFT® in Acute Allergic ConjunctivitisWho this might be right forConjunctivitis, Allergic Allergan 127
Large-scale testing (Phase 3)Study completedNCT01561521What this trial is testingAn Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Akorn, Inc. 90
Not applicableStudy completedNCT00266734What this trial is testingEvaluation of a Rapid Screening Test for Detection of Adenovirus in TearsWho this might be right forAcute ConjunctivitisAdenoviral Conjunctivitis Rapid Pathogen Screening 186
Not applicableStudy completedNCT02112773What this trial is testingADenoVirus Initiative Study in Epidemiology in UKWho this might be right forViral Conjunctivitis NicOx 31
Large-scale testing (Phase 3)Study completedNCT01551056What this trial is testingA Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)Who this might be right forAllergic Conjunctivitis Aciex Therapeutics, Inc. 91
Not applicableStudy completedNCT02054234What this trial is testingADenoVirus Initiative Study in Epidemiology in FranceWho this might be right forViral Conjunctivitis NicOx 357
Testing effectiveness (Phase 2)Study completedNCT01470664What this trial is testingFST-100 in the Treatment of Acute Adenoviral ConjunctivitisWho this might be right forAcute Adenoviral Conjunctivitis Shire 176
Testing effectiveness (Phase 2)Study completedNCT03320434What this trial is testingStudy Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis ORA, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT03749317What this trial is testingTrial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral ConjunctivitisWho this might be right forAdenoviral Conjunctivitis IVIEW Therapeutics Inc. 135
Testing effectiveness (Phase 2)UnknownNCT03856645What this trial is testingOKG-0301 for the Treatment of Acute Adenoviral ConjunctivitisWho this might be right forAdenoviral Conjunctivitis Okogen 219